Adrenocorticotropic Hormone (ACTH) (1-39), human 1-39-Corticotropin (human),98.07%
产品编号:Bellancom-P1211| CAS NO:12279-41-3| 分子式:C207H308N56O58S| 分子量:4541.14
Adrenocorticotropic Hormone (ACTH) (1-39), human 是一种黑皮质素受体 (melanocortin receptor) 激动剂。
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用,
Adrenocorticotropic Hormone (ACTH) (1-39), human 1-39-Corticotropin (human)
产品介绍 | Adrenocorticotropic Hormone (ACTH) (1-39), human 是一种黑皮质素受体 (melanocortin receptor) 激动剂。 | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
生物活性 | Adrenocorticotropic Hormone (ACTH) (1-39), human is a melanocortin receptor agonist. | ||||||||||||||||
体外研究 |
Adrenocorticotropic Hormone (ACTH) (1-39), human (ACTH 1-39), a member of the melanocortin family, stimulates production of CS by the adrenals, but melanocortin receptors are also found in the central nervous system (CNS) and on immune cells. ACTH 1-39 protects neurons in vitro from several apoptotic, excitotoxic and inflammation-related insults. The conditioned medium (CM) is prepared from untreated astroglia (AS) cultures and from AS cultures treated with 200 nM ACTH 1-39 for 24 h, washed to remove ACTH 1-39, then incubated for another 24 h in DMEM. In initial experiments, no difference is found in oligodendroglia (OL) viability in the presence of OL definedmediumwith 2% newborn calf serum (NCS) or AS CM (prepared in DMEM with no serum). After 24 h, OL death under each condition varies between 1 and 4%. Similar results for OL viability are obtained with microglia (MG) CM. In subsequent experiments, controls in each experiment consist of OL in defined medium with 2% NCS. 西域 has not independently confirmed the accuracy of these methods. They are for reference only. | ||||||||||||||||
体内研究 | |||||||||||||||||
体内研究 | |||||||||||||||||
性状 | Solid | ||||||||||||||||
溶解性数据 |
In Vitro:
H2O : ≥ 50 mg/mL (11.01 mM) * "≥" means soluble, but saturation unknown. 配制储备液
*
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo:
请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
*以上所有助溶剂都可在 西域 网站选购。
| ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
Sealed storage, away from moisture and light, under nitrogen
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light, under nitrogen) | ||||||||||||||||
参考文献 |
|
符号 |
![]() ![]() GHS07, GHS08 |
---|---|
信号词 | Warning |
危害声明 | H302-H312-H332-H351 |
警示性声明 | P280 |
个人防护装备 | Eyeshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges |
危害码 (欧洲) | Xn: Harmful; |
风险声明 (欧洲) | R20/21/22 |
安全声明 (欧洲) | 22-36 |
危险品运输编码 | NONH for all modes of transport |
WGK德国 | 3 |
RTECS号 | GM7900000 |

匹配竞争对手的价格

效率为先

专业经验 贴心服务

50000+库存